US 9975944
Synthetic peptides for the treatment of autoimmune diseases
granted A61KA61K38/00A61P
Quick answer
US patent 9975944 (Synthetic peptides for the treatment of autoimmune diseases) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P19/02